Skip to main content

Table 4 Patient-reported adverse events

From: Artemether–lumefantrine and dihydroartemisinin–piperaquine treatment outcomes among children infected with uncomplicated Plasmodium falciparum malaria in Mwanza, Tanzania

Adverse effect ALU DHP
Patient reported N (%) Patient reported N (%)
Headache (yes) n (%) 98 12 (12.24%) 88 8 (9.09%)
Nausea and vomiting (yes) n (%) 99 14 (14.14%) 87 3 (3.45%)
Cough (yes) n (%) 99 4 (4.04%) 88 0
Diarrhea (yes) n (%) 98 1 (1.02%) 88 3 (3.41%)
Loss appetite (yes) n (%) 93 5 (5.38%) 89 1 (1.12%)
Abdominal pain (yes) n (%) 98 13 (13.27%) 86 7 (8.14%)